Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-26-060317
Filing Date
2026-05-13
Accepted
2026-05-13 16:42:04
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6581
  Complete submission text file 0001104659-26-060317.txt   8270
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Subject) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91004 | Film No.: 26974129
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 20 PARK PLAZA SUITE 620 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 620 BOSTON MA 02116 617.284.6952
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001816307 (see all company filings)

EIN.: 834542901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A